Accelerating Innovation at Leica Biosystems

Portfolio Evolution: A Stronger, Better Danaher CORE REVENUE GROWTH RECURRING REVENUE OPERATING PROFIT MARGIN FREE CASH FLOW +LDD ~75% >$6B >25% ~17% +LSD ~45% >$3B 2015 2019- 21E 2015 2021E 2015 2021E 2015 2021E 2015 metrics shown include Fortive and Envista.. Recurring Revenue is shown as a % of total revenue. 2019-21E core growth is avg. annual core growth for '19, '20, '21E. Focus on growth and business model drives superior performance DANAHER

View entire presentation